Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Xi-Jing Qian"'
Publikováno v:
Emerging Microbes and Infections, Vol 5, Iss 1, Pp 1-8 (2016)
Hepatitis C virus (HCV) infection affects approximately 3% of the world’s population and causes chronic liver diseases, including liver fibrosis, cirrhosis, and hepatocellular carcinoma. Although current antiviral therapy comprising direct-acting a
Externí odkaz:
https://doaj.org/article/b3ece54c111b47378874a9356e9df4ba
Autor:
Yong-Zhe Zhu, Da-Ge Wu, Hao Ren, Qing-Qiang Xu, Kui-Cheng Zheng, Wei Chen, Sheng-Lin Chen, Xi-Jing Qian, Qing-Yuan Tao, Yan Wang, Ping Zhao, Zhong-Tian Qi
Publikováno v:
Cellular Physiology and Biochemistry, Vol 35, Iss 4, Pp 1347-1359 (2015)
Background/Aims: Although it has been widely accepted that Enterovirus 71 (EV71) enters permissive cells via receptor-mediated endocytosis, the details of entry mechanism for EV71 still need more exploration. This study aimed to investigate the role
Externí odkaz:
https://doaj.org/article/2d861eff9e7e449b9365550735c4afef
Autor:
Xi-Jing, Qian, Zhong-Tian, Qi
Publikováno v:
Advances in experimental medicine and biology. 1366
Hepatitis C virus (HCV) infection affects approximately 1% of the world's population and is a major cause of chronic liver diseases. Although antiviral therapy consisting of direct-acting antivirals (DAAs) can cure the majority of HCV patients, it is
Autor:
Xi-Jing Qian, Zhong-Tian Qi
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9789811687013
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d95200e26e2e2d9f2bfff4d1e7310dc
https://doi.org/10.1007/978-981-16-8702-0_13
https://doi.org/10.1007/978-981-16-8702-0_13
Autor:
Xi-Jing, Qian, He-Yang, Zhou, Yan, Liu, Jia-Xiao, Dong, Wan-Da, Tang, Ping, Zhao, Hai-Lin, Tang, Yong-Sheng, Jin
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 72:128863
Natural plant-derived baicalein which is extracted from Chinese herb Scutellaria baicalensis Georgi belongs to the flavonoid compounds and possesses multiple pharmacological activities. In this study, we designed and synthesized new series of derivat
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
Frontiers in Microbiology
Frontiers in Microbiology
Hepatitis C virus (HCV) infection involves a variety of viral and host factors, some of which promote the infection process. A small nucleolar RNA, C/D box 126 (SNORD126), was previously shown to be associated with hepatocellular carcinoma (HCC). How
Exosomal MicroRNAs Derived From Umbilical Mesenchymal Stem Cells Inhibit Hepatitis C Virus Infection
Publikováno v:
Stem Cells Translational Medicine, Vol 5, Iss 9, Pp 1190-1203 (2016)
Hepatitis C virus (HCV) is a significant global public health problem, causing more than 350,000 deaths every year. Although the development of direct-acting antivirals has improved the sustained virological response rate in HCV patients, novel anti-
Autor:
Yue Wang, Chen Xu, Chun-Yu Xue, Houqi Liu, Xin Xing, Xi-Jing Qian, Yuntong Zhang, Minjuan Wu, Chao Yang, Hongda Bi, Shuo Fang, Kaihong Ji, Yunpeng Zhao
Publikováno v:
Stem Cells Translational Medicine. 5:1425-1439
Excessive scar formation caused by myofibroblast aggregations is of great clinical importance during skin wound healing. Studies have shown that mesenchymal stem cells (MSCs) can promote skin regeneration, but whether MSCs contribute to scar formatio
Publikováno v:
Virology. 492:155-165
HCV infection has a complex and dynamic process which involves a large number of viral and host factors. Long non-coding RNA GAS5 inhibits liver fibrosis and liver tumor migration and invasion. However, the contribution of GAS5 on HCV infection remai
Publikováno v:
Emerging Microbes & Infections
Hepatitis C virus (HCV) infection affects approximately 3% of the world's population and causes chronic liver diseases, including liver fibrosis, cirrhosis, and hepatocellular carcinoma. Although current antiviral therapy comprising direct-acting ant